{"entity":{"type":"insider","cik":"0001837374","url":"/insider/0001837374","json_url":"/insider/0001837374.json","name":"Leversage Jill","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2021-02-02","last":"2024-05-22","span_basis":"filed_date"},"name_variants":[{"name":"Leversage Jill","source":"filing","n_filings":5,"first_seen":"2021-02-02","last_seen":"2024-05-22"}],"transactions":[{"id":3260754,"accession":"0001600620-24-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001600620-24-000072","line_url":"/filing/0001600620-24-000072#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837374","owner_name":"Leversage Jill","owner_url":"/insider/0001837374","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5610.0,"shares_display":"5,610","price_per_share":5.74,"price_display":"5.74","price_state":"stated","total_value":32201.4,"total_display":"32,201.40","shares_owned_after":12918.0,"shares_owned_after_display":"12,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-22","scope":"insider"},{"id":8715307,"accession":"0001600620-23-000017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001600620-23-000017","line_url":"/filing/0001600620-23-000017#line-3","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837374","owner_name":"Leversage Jill","owner_url":"/insider/0001837374","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4815.0,"shares_display":"4,815","price_per_share":11.26,"price_display":"11.26","price_state":"stated","total_value":54216.9,"total_display":"54,216.90","shares_owned_after":18528.0,"shares_owned_after_display":"18,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-23","scope":"insider"},{"id":5267503,"accession":"0001628280-21-025130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-025130","line_url":"/filing/0001628280-21-025130#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837374","owner_name":"Leversage Jill","owner_url":"/insider/0001837374","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1600.0,"shares_display":"1,600","price_per_share":20.04,"price_display":"20.04","price_state":"stated","total_value":32064.0,"total_display":"32,064.00","shares_owned_after":5300.0,"shares_owned_after_display":"5,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider"},{"id":5419170,"accession":"0001628280-21-010018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-010018","line_url":"/filing/0001628280-21-010018#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837374","owner_name":"Leversage Jill","owner_url":"/insider/0001837374","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":10.9557,"price_display":"10.96","price_state":"stated","total_value":27389.25,"total_display":"27,389.25","shares_owned_after":3700.0,"shares_owned_after_display":"3,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-12","scope":"insider"},{"id":4333605,"accession":"0001628280-21-001281","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-21-001281","line_url":"/filing/0001628280-21-001281#line-2","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837374","owner_name":"Leversage Jill","owner_url":"/insider/0001837374","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":16.03,"price_display":"16.03","price_state":"stated","total_value":19236.0,"total_display":"19,236.00","shares_owned_after":1200.0,"shares_owned_after_display":"1,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-29","filed_date":"2021-02-02","scope":"insider"},{"id":4333600,"accession":"0001628280-21-001281","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-21-001281","line_url":"/filing/0001628280-21-001281#line-1","is_derivative":false,"issuer_cik":"0001600620","issuer_name":"Aurinia Pharmaceuticals Inc.","issuer_ticker":"AUPH","issuer_name_source":null,"issuer_url":"/issuer/0001600620","owner_cik":"0001837374","owner_name":"Leversage Jill","owner_url":"/insider/0001837374","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":16.03,"price_display":"16.03","price_state":"stated","total_value":6412.0,"total_display":"6,412.00","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-29","filed_date":"2021-02-02","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600620","name":"Aurinia Pharmaceuticals Inc.","url":"/issuer/0001600620","role":"Director","n_filings":5,"first_seen":"2021-02-02","last_seen":"2024-05-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001837374","retrieved_at":"2026-08-20T18:17:56+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}